Morning session : new developments

Chairwoman : B. Gulbis (LHUB-ULB)

• 08:15 · Welcome & Coffee
• 08:45 · Introduction | F. Cotton (LHUB-ULB)
• 09:00 · Discovery of new markers | B. Leroy (MS-Quanta – UMons)
• 09:30 · The pathway through LC-MS method development: homemade or kit-based? | C. Le Goff (Unilab – ULg)
• 10:00 · Immunosuppressants on the Sciex Topaz system | D. Fage / G. Deprez (LHUB-ULB)
• 10:30 · coffee break
• 11:00 · Assessment of the lipoproteins quality by LC-MS/MS | P. Van Antwerpen (Faculty of Pharmacy – ULB)
• 11:30 · Steroids on the Sciex Citrine system | F. Wolff / G. Deprez (LHUB-ULB)
• 12:00 · Underivatized method for the newborn screening of aminoacids and acylcarnitines | F. Boemer (Unilab – ULg)
• 12:30 · Column-switching LC-MS/MS for simultaneous measurement of all 4 NOACs | D. Borrey (AZ St Jan – Brugge)

Mid-day session

• 13:00 · lunch
• 13:30 · Demonstration of the Sciex Topaz and Citrine systems in the special biochemistry lab | G. Deprez

Reservation mandatory

Afternoon session : the future of mass spectrometry in light of the upcoming IVDR

Chairman : O. Vandenberg (LHUB-ULB)

• 14:00 · Merger of university clinical labs: challenges and pitfalls | J. Vanderlinden (LHUB-ULB)
• 14:30 · The challenge of IVDR | J. Poels & S. Schouteden (AFMPS/FAGG)
• 15:15 · Impact of IVDR on clinical labs activities | N. De Vos (LHUB-ULB)
• 15:45 · Round table | F. Boemer, N. De Vos, C. Le Goff, J. Poels, S. Schouteden - Moderation: F. Cotton
• 17:00 · Future insights in clinical mass spectrometry – the rise of precision medicine | Dan Blake (Sciex)
• 17:30 · Conclusions | F. Cotton (LHUB-ULB)